Plantar fasciitis is a common degenerative condition of the plantar fascia at the medial calcaneal tuberosity, affecting about 10% of the population annually. Symptoms include heel pain, morning stiffness, and difficulty in daily activities. Current treatments include physiotherapy, wax therapy, NSAIDs, and corticosteroid injections; however, long-term use of steroids and NSAIDs may cause adverse effects. In Ayurveda, the condition is correlated with Vatakantaka, for which classics prescribe Raktamokshana (siravyadha) and Erandataila Pana .

Modern studies highlight the role of wax therapy and stretching exercises in improving circulation, pain, and function, though requiring frequent sessions. Case studies on Raktamokshana with Erandataila suggest significant improvement with fewer sittings, indicating cost-effectiveness and reduced patient burden.

This open-label, double-arm comparative clinical trial will recruit 36 patients (20–65 yrs) with plantar fasciitis from OPD/IPD of Amrita School of Ayurveda. Group A will receive Raktamokshana (Siravyadha, 3 sittings) with Erandataila Pana (10 ml daily), while Group B will undergo Wax therapy (10 sessions) with Exercise. Assessments will be made using VAS score, Foot Function Index (FFI), ankle range of motion, and Windlass test over 15 days.

The research hypothesis states that there is a significant difference between the two interventions in reducing pain, improving foot function, and ankle range of motion. Statistical analysis will be done using Independent t-test / Mann–Whitney U test, and Friedman test for intra-group comparisons.

The study aims to establish whether fewer sessions of Raktamokshana with Erandataila Pana can provide results comparable or superior to conventional wax therapy with exercise, potentially offering an effective and economical treatment option for plantar fasciitis.